Kathryn Miles is a Senior Analyst in the pharmaceutical team at the NIHR Horizon Scanning Research & Intelligence Centre (NIHR HSRIC). She currently jointly leads engagement with pharmaceutical companies to identify significant developments likely to have an impact on the NHS in the next three years. In addition, she manages liaison with the National Institute for Health and Care Excellence (NICE) topic selection programme.
Since 2012, Kathryn has jointly led the HSRIC Patient and Public Involvement (PPI) and Engagement strategy presenting findings at HTAi conference in Washington 2014 and NIHR INVOLVE conference 2014.
As part of her pharmaceutical work, Kathryn carried out research into emerging orphan drugs, presenting her findings at HTAi conference in Rome in 2005, with final publication in QJM in 2007. More recently, she has worked on a review of biomarkers in development for Alzheimer's disease presented by poster at HTAi conference Bilbao in 2012. During her time at NIHR HSRIC, Kathryn completed a Masters in Public Health.
Other professional research interests include the impact of gardening on health and wellbeing.
Miles K, Cook A. Involving patients to review a website: positive first experiences. INVOLVE conference 2014: Changing landscapes; 2014 November; NEC, Birmingham.
Miles K, Cook A, Packer C. Patient and Public Involvement (PPI) and Engagement in Early Awareness and Alerts (EAA) activities in England. Health Technology Assessment International 11th Annual Meeting; 2014 June; Washington DC, USA. OR12.4;37.
Fletcher L, Burke K, Caine P, Rinne N, Braniff C, Davis H, Miles K, Packer C. Diagnosing Alzheimer’s disease: are we any nearer to useful biomarker-based, non-invasive tests? GMS Health Technology Assessment 2013;9:ISSN 1861-8863.
Fletcher L, Burke K, Caine P, Rinne N, Braniff C, Davis H, Miles K, Packer C. Definitive diagnosis of Alzheimer’s in the GP surgery: a search for biomarkers. Health Technology Assessment International 9th Annual Meeting; 2012 June. Bilbao, Spain. Gaceta Sanitaria;2012;26 (Especial Congreso 2);234.
Braniff C, Burke K, Caine P, Davis H, Fletcher L, Rinne N, Miles K, Packer C. New and emerging molecular biomarkers for the diagnosis of Alzheimer’s disease in patients with mild cognitive impairment. Alzheimer’s Research UK conference; 2012 March; Birmingham, UK.
Miles K, Packer C and Stevens A. Quantifying emerging drugs for rare conditions. Quarterly Journal of Medicine 2007;100:291-295.
Miles K, Packer C, Stevens A. The identification and categorisation of emerging pharmaceuticals for ‘ultra-orphan’ conditions. Health Technology Assessment International 2nd Annual Meeting; 2005 June; Rome, Italy. Italian Journal of Public Health 2005;2:2 (supplement 1);162.
Adab P, Rankin E, Witney A, Miles K, Bowman S, Kitas G, Situnayake D, and Bacon P. Use of a corporate needs assessment to define the information requirements of an arthritis resource centre in Birmingham: comparison of patients’ and professionals’ views. Rheumatology 2004;43:1513-1518.
Adab P, Smith K, Booth D, Kitas G, Situnayake D, Bowman S, Rankin E, Hall M and Bacon P. Measuring success of an arthritis resource centre.Society for Rheumatology XVIII Annual General Meeting; 2001 April; UK. Rheumatology 2001;40 (supplement 1);62.